Bli medlem
Bli medlem

Du är här


LivaNova PLC : LivaNova PLC to Present at the Credit Suisse Annual Healthcare Conference

(LSE:LIVN) ("LivaNova" or the "Company"), a market-leading medical technology
and innovation company, today announced that André-Michel Ballester, Chief
Executive Officer of LivaNova, and Vivid Sehgal, Chief Financial Officer of
LivaNova, will both be participating in a discussion at the Credit Suisse
Healthcare Conference on Tuesday, November 8, 2016.

The discussion is scheduled to begin at 11:00 a.m. Mountain Standard Time on
Tuesday, November 8, 2016. It will be available to all interested parties
through a live audiocast accessible via the investor relations section of
LivaNova's website at Listeners should log on
approximately 10 minutes in advance to ensure proper setup to receive the
audiocast. A replay of the webcast will be available on the LivaNova website
approximately 24 hours after the live presentation for 90 days after the

About LivaNova

LivaNova PLC is a global medical technology company formed by the merger of
Sorin S.p.A, a leader in the treatment of cardiovascular diseases, and
Cyberonics Inc., a medical device company with core expertise in
neuromodulation. LivaNova transforms medical innovation into meaningful
solutions for the benefit of patients, healthcare professionals, and
healthcare systems.

The Company employs approximately 4,600 employees worldwide and is
headquartered in London, U.K.

For more information, please visit, or contact:
Investor Relations and Media
Karen King

Vice President, Investor Relations&Corporate Communications
Phone: +1 (281) 228-7262
Fax: +1 (281) 218-9332


This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: LivaNova PLC via Globenewswire

Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.